Calithera Biosciences, Inc.

CALACIK 0001496671 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 31, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0073

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Calithera Biosciences, Inc.

Name	Roles	Filings
Kuriakose Emil	Officer	4
Sjogren Eric	Officer	4
Wong Stephanie	Officer	4
Parlati Francesco	Officer	3
Molineaux Christopher	Officer	2

Showing 1-5 of 16

Per pagePage 1 of 4Next

All filings

30 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 26, 2023	Takeda Pharmaceutical Co Ltd Other	Holdings only	-	-	-
Jan 31, 2023	Pakianathan Deepika Director	SSale	120,161	$0.3858	$46,358
Jan 25, 2023	Molineaux Christopher SR. VP, DEVELOPMENT	FTax	217	$0.4461	$97
Jan 25, 2023	Wong Stephanie See Remarks	FTax	317	$0.4461	$141
Jan 25, 2023	Molineaux Susan PRESIDENT & CEO · Director	FTax	526	$0.4461	$235

Showing 1-5 of 30

Per pagePage 1 of 6Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value